IQVIA Holdings Inc (IQV) - Financial and Strategic SWOT Analysis Review
February 2019
59
About the Report
About the Report
IQVIA Holdings Inc (IQV)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
- Business description - A detailed description of the company's operations and business divisions.
- Corporate strategy - Analyst's summarization of the company's business strategy.
- SWOT Analysis - A detailed analysis of the company's strengths, weakness, opportunities and threats.
- Company history - Progression of key events associated with the company.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Executive biographies - A brief summary of the executives' employment history.
- Key operational heads - A list of personnel heading key departments/functions.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities - A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights
IQVIA Holdings Inc (IQVIA), formerly Quintiles IMS Holdings, Inc, is a provider of information, novel technological solutions and contract research services, by harnessing data and science, to healthcare companies. The company offers a wide range of solutions in clinical development, commercialization and technologies, and helps stimulate significant healthcare outcomes. Its IQVIA CORE is a customized solution that provides actionable insights through big data, transformative technology and analytics with wide industry knowledge in diseases, regions, human behaviors and scientific advances. IQVIA serves biotech, medical device and pharmaceutical companies; medical researchers, government agencies, patient associations, payers and investigators, among others. The company has operations in Asia, Europe, the Americas, the Middle East and Africa. IQVIA is headquartered in Durham, North Carolina, the US.
IQVIA Holdings Inc Key Recent Developments
Feb 04,2019: IQVIA Launches IQVIA Biotech, Dedicated to Emerging Biotech and Biopharma Industry
Jan 31,2019: IQVIA Launches Next Generation Site Portal Technology Capabilities to Streamline Clinical Trial ...
Jan 30,2019: IQVIA to Announce Fourth-Quarter and Full-Year 2018 Results and Issue 2019 Guidance on February 14, 2019
Jan 19,2019: Iqvia launches new division to support emerging biotech market
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
Products
Products
IQVIA Holdings Inc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts
Companies
Verisk Analytics, Inc.
Veeva Systems Inc
PRA Health Sciences Inc
Parexel International Corp
OptumHealth, Inc.
MedeAnalytics Inc
Acxiom Corp
Table of Contents
Table of Contents
Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1-About the Company
IQVIA Holdings Inc-Key Facts
IQVIA Holdings Inc-Key Employees
IQVIA Holdings Inc-Key Employee Biographies
IQVIA Holdings Inc-Major Products and Services
IQVIA Holdings Inc-History
IQVIA Holdings Inc-Company Statement
IQVIA Holdings Inc-Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2 - Company Analysis
Company Overview
IQVIA Holdings Inc-Business Description
Business Segment: Commercial Solutions
Overview
Performance
Business Segment: Integrated Engagement Services
Overview
Performance
Business Segment: Research & Development Solutions
Overview
Performance
Geographical Segment: Americas
Performance
Geographical Segment: Asia-Pacific
Performance
Geographical Segment: Europe and Africa
Performance
IQVIA Holdings Inc-Corporate Strategy
IQVIA Holdings Inc-SWOT Analysis
SWOT Analysis-Overview
IQVIA Holdings Inc-Strengths
IQVIA Holdings Inc-Weaknesses
IQVIA Holdings Inc-Opportunities
IQVIA Holdings Inc-Threats
IQVIA Holdings Inc-Key Competitors
Section 3 - Company Financial Ratios
Financial Ratios-Capital Market Ratios
Financial Ratios-Annual Ratios
Performance Chart
Financial Performance
Financial Ratios-Interim Ratios
Financial Ratios-Ratio Charts
Section 4 - Company's Lifesciences Financial Deals and Alliances
IQVIA Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
IQVIA Holdings Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
IQVIA Holdings Inc, Recent Deals Summary
Section 5 - Company's Recent Developments
Feb 04, 2019: IQVIA Launches IQVIA Biotech, Dedicated to Emerging Biotech and Biopharma Industry
Feb 04, 2019: IQVIA launches IQVIA Biotech, dedicated to emerging biotech and biopharma industry
Jan 30, 2019: IQVIA to Announce Fourth-Quarter and Full-Year 2018 Results and Issue 2019 Guidance on February 14, 2019
Dec 06, 2018: IQVIA Named Best Contract Research Organization Full-Service Provider in 2018 Scrip Awards
Nov 29, 2018: IQVIA s OCE Technology Platform Selected by Napo Pharmaceuticals to Increase Commercial Efficiency
Nov 27, 2018: IQVIA s orchestrated customer engagement selected by Novo Nordisk international operations
Nov 27, 2018: IQVIAs orchestrated customer engagement selected by Novo Nordisk international operations
Nov 20, 2018: Adhera Therapeutics selects IQVIA's OCE technology platform to support commercial excellence
Oct 30, 2018: Public Release: 30-Oct-2018 Life-changing intersection between big data and therapeutic pipeline in neuromuscular disease MWW Group A new report funded by the Muscular Dystrophy Association (MDA) and released by the IQVIA Institute for Human Data Science
Oct 18, 2018: Xeloda Adherence Support App Contributes to Improving Communication between Cancer Patients and Healthcare Providers
Section 6 - Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Figure
List of Figures
IQVIA Holdings Inc, Performance Chart (2013-2017)
IQVIA Holdings Inc, Ratio Charts
IQVIA Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
IQVIA Holdings Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019
List of Table
List of Tables
IQVIA Holdings Inc, Key Facts
IQVIA Holdings Inc, Key Employees
IQVIA Holdings Inc, Key Employee Biographies
IQVIA Holdings Inc, Major Products and Services
IQVIA Holdings Inc, History
IQVIA Holdings Inc, Other Locations
IQVIA Holdings Inc, Subsidiaries
IQVIA Holdings Inc, Joint Venture
IQVIA Holdings Inc, Key Competitors
IQVIA Holdings Inc, Ratios based on current share price
IQVIA Holdings Inc, Annual Ratios
IQVIA Holdings Inc, Annual Ratios (Cont...1)
IQVIA Holdings Inc, Annual Ratios (Cont...2)
IQVIA Holdings Inc, Interim Ratios
IQVIA Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
IQVIA Holdings Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
IQVIA Holdings Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.